Core Laboratories (CLB) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Simmons Remains Sidelined on Core Laboratories (CLB) - PT to $115
April 22, 2016 9:30 AM EDTSimmons maintained a Neutral rating on Core Laboratories (NYSE: CLB), and raised the price target to $115.00 (from $105.00), following the company's 1Q earnings review.
Analyst Bill Herbert commented, "Respectable quarter given oppressive conditions. While CLB's value proposition provides the company above average... More

